Our results also suggest that MCH and MCHR1-mediated cAMP-PKA signaling may regulate noradrenaline producing enzymes in the LC and noradrenergic dysregulation may underlie the occurrence of depression-like behaviors. This evidence concerns the gene MCHR1 and depressive symptom measurement.